You are here: Industry Insights > trial

News List

Trial findings back wider use of Roche’s Hemlibra pharmatimes
May 24, 2018
Currently, the therapy is approved to treat those with the condition who have factor VIII inhibitors, that is antibodies causing resistance to replacement clotting factors.
Avenue Announces Positive Phase 3 Trial Results contractpharma
May 22, 2018
Avenue Therapeutics announced that its first pivotal Phase 3 trial of IV tramadol achieved the primary endpoint of a statistically significant improvement
PaxVax Announces the Initiation of Phase 2b Trial for its Chikungunya Vaccine americanpharmaceuticalreview
April 27, 2018
PaxVax announced the enrollment of the first patient in its Phase 2b dose-finding trial of the chikungunya virus-like particle (VLP) vaccine
Personalized tumor vaccine shows promise in pilot trial worldpharmanews
April 16, 2018
A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania.
AbbVie’s Arthritis Drug Dazzles in Phase III Trial biospace
April 10, 2018
AbbVie announced positive top-line data from its Phase III SELECT-COMPARE clinical trial of upadacitinib in moderate to severe rheumatoid arthritis.
Incyte Nosedives: Drug Combo Fails Melanoma Phase III Trial biospace
April 08, 2018
Shares of Incyte Corporation are down more than 20 percent this morning after the company revealed that pairing is IDO1 drug in combination with Merck’s Keytruda failed to meet endpoints in a Phase III melanoma trial.
Regeneron's Eylea smashes Phase 3 trial goal in diabetic retinopathy pharmafile
March 21, 2018
Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection of Eylea (Aflibercept) reached its primary endpoint in a recent phase III study
Alexion's Prospects Rise with Positive Phase III Trial Data biospace
March 16, 2018
Alexion Pharmaceuticals Inc., headquartered in New Haven, Connecticut, announced positive results from its pivotal Phase III clinical trial of ALXN1210 in paroxysmal nocturnal hemoglobinuria (PNH).
Auris Medical Fails Again in Phase III Trial biospace
March 15, 2018
Auris Medical AG has gone down swinging again in attempting to develop a treatment for tinnitus and investors are not happy about it at all.
Aeglea BioTherapeutics Updates Phase I/II Trial Data biospace
March 14, 2018
Aeglea Biotherapeutics, headquartered in Austin, Texas, announced new repeat dose data from its Phase I/II trial of AEB1102 (pegzilarginase) in patients with Arginase 1 Deficiency.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page